[1]
Garcia Neves, G.J., Quevedo, A.L. and Lupi Júnior, L.A. 2024. Advances in Immunotherapy for Triple-Negative Breast Cancer: Efficacy, Safety, and Predictive Biomarkers of Response with Anti-PD1 and Anti-PDL1. Brazilian Journal of Implantology and Health Sciences . 6, 9 (Sep. 2024), 2321–2333. DOI:https://doi.org/10.36557/2674-8169.2024v6n9p2321-2333.